Please join us for a discussion on “Unraveling the Complexity of Bronchiectasis: A Guide for Internists and Primary Care Caregivers” with Anas Hadeh, M.D.
Dr. Hadeh will discuss the burden of disease, patient risk factors, and comorbidities associated with bronchiectasis; review the diagnostic evaluation as recommended by society guidelines; and discuss other aspects of this disease.
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers
- Discuss the burden of bronchiectasis, patient risk factors, and comorbidities associated with the disease.
- Review the diagnostic evaluation as recommended by society guidelines.
- Describe the impact of pulmonary exacerbations in the natural history, clinical course, and disease progression of bronchiectasis.
- Evaluate the impact of airway clearance, antibiotics and anti-inflammatory therapies on disease management approaches for bronchiectasis.
FACULTY AND DISCLOSURES:
Anas Hadeh, M.D., FCCP
Director, Pulmonary and Critical Care Medicine Fellowship Program
Affiliate Associate Professor of Clinical Biomedical Science
FAU Charles E. Schmidt College of Medicine
Boca Raton, Florida
Clinical Assistant Professor of Medicine in the Cleveland Clinic Lerner College of
Medicine of Case Western Reserve University
Cleveland Clinic Florida
Anas Hadeh, M.D., FCCP, faculty for this educational activity, is a speaker for Insmed and GlaxoSmithKline, an advisor for Insmed, GlaxoSmithKline, Nabriva and Merck, and a grant recipient. Dr. Hadeh has indicated that the presentation or discussion will include off-label or unapproved product usage.
John F. Rubin, M.D., FACP, director of this educational activity, has indicated that he is a shareholder in AstraZeneca and Bristol-Myers Squibb. All of the relevant financial relationships listed for this individual have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
ACCREDITATION STATEMENTS AND CREDITS
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.
This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Florida Board of Athletic Training
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dentistry
- 1.00 Florida Board of Dietitians
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy